GlycoMimetics
GLYC
#10282
Rank
NZ$17.41 M
Marketcap
NZ$0.27
Share price
-5.42%
Change (1 day)
-41.79%
Change (1 year)

Market capitalization of GlycoMimetics (GLYC)

Last known market cap: NZ$17.41 Million

As of March 2026 GlycoMimetics has a market cap of NZ$17.41 Million. This makes GlycoMimetics the world's 10282th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlycoMimetics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$17.41 M-0.47%
2025NZ$17.49 M-35.28%
2024NZ$27.02 M-88.75%
2023NZ$0.24 B-3.95%
2022NZ$0.25 B129.37%
2021NZ$0.10 B-57.3%
2020NZ$0.25 B-25.19%
2019NZ$0.34 B-43.97%
2018NZ$0.60 B-24.94%
2017NZ$0.81 B299.66%
2016NZ$0.20 B27.58%
2015NZ$0.15 B-8.52%
2014NZ$0.17 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$982.73 B 5,643,867.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$266.98 B 1,533,219.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$181.42 B 1,041,825.46%๐Ÿ‡ซ๐Ÿ‡ท France
Palatin Technologies
PTN
NZ$65.42 M 275.73%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
NZ$83.64 M 380.37%๐Ÿ‡บ๐Ÿ‡ธ USA